Literature DB >> 8090277

Melatonin is able to influence its secretion in humans: description of a phase-response curve.

R Zaidan1, M Geoffriau, J Brun, J Taillard, C Bureau, G Chazot, B Claustrat.   

Abstract

A single physiological dose of melatonin (20 micrograms for 3 h given intravenously at different times of the day (04.00-12.00, 16.00 and 20.00 h) was able to shift the endogenous plasma melatonin profile of healthy volunteers under entrained conditions according to a phase-response curve (PRC). ANOVA showed an effect of the time of administration on the onset, the acrophase or the offset of the melatonin profiles. These profiles were significantly delayed when the infusion was administered at 12.00 h and advanced when the infusion was given at 20.00 h. Further, the AUCs evaluated on the nocturnal melatonin profiles were increased after the 04.00 h infusion (+20.5%, p < 0.05), whereas they were decreased after the 12.00 h infusion (-20%, p < 0.05). Lastly, no alteration was observed for cortisol rhythm, whatever the time of melatonin administration. These results, which show that according to a PRC the system regulating melatonin secretion is sensitive to a single short-term administration of the hormone given at a low dose, support the paradigm of the endogenous synchronizer melatonin.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8090277     DOI: 10.1159/000126726

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  12 in total

1.  Circadian Rhythm Sleep Disorders.

Authors: 
Journal:  Curr Treat Options Neurol       Date:  1999-09       Impact factor: 3.598

2.  Circadian periods of sensitivity for ramelteon on the onset of running-wheel activity and the peak of suprachiasmatic nucleus neuronal firing rhythms in C3H/HeN mice.

Authors:  Oliver Rawashdeh; Randall L Hudson; Iwona Stepien; Margarita L Dubocovich
Journal:  Chronobiol Int       Date:  2011-02       Impact factor: 2.877

3.  A three pulse phase response curve to three milligrams of melatonin in humans.

Authors:  Helen J Burgess; Victoria L Revell; Charmane I Eastman
Journal:  J Physiol       Date:  2007-11-15       Impact factor: 5.182

Review 4.  The impact of the circadian timing system on cardiovascular and metabolic function.

Authors:  Christopher J Morris; Jessica N Yang; Frank A J L Scheer
Journal:  Prog Brain Res       Date:  2012       Impact factor: 2.453

5.  Melatonin phase shifts human circadian rhythms in a placebo-controlled simulated night-work study.

Authors:  Katherine M Sharkey; Charmane I Eastman
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2002-02       Impact factor: 3.619

6.  A mathematical model of the circadian phase-shifting effects of exogenous melatonin.

Authors:  Emily R Breslow; Andrew J K Phillips; Jean M Huang; Melissa A St Hilaire; Elizabeth B Klerman
Journal:  J Biol Rhythms       Date:  2013-02       Impact factor: 3.182

Review 7.  Optimal dosages for melatonin supplementation therapy in older adults: a systematic review of current literature.

Authors:  Esmée M S Vural; Barbara C van Munster; Sophia E de Rooij
Journal:  Drugs Aging       Date:  2014-06       Impact factor: 3.923

8.  A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer's disease.

Authors:  Clifford Singer; Rochelle E Tractenberg; Jeffrey Kaye; Kim Schafer; Anthony Gamst; Michael Grundman; Ronald Thomas; Leon J Thal
Journal:  Sleep       Date:  2003-11-01       Impact factor: 5.849

9.  Clinical applications of melatonin in circadian disorders.

Authors:  Alfred J Lewy
Journal:  Dialogues Clin Neurosci       Date:  2003-12       Impact factor: 5.986

Review 10.  Comparative Review of Approved Melatonin Agonists for the Treatment of Circadian Rhythm Sleep-Wake Disorders.

Authors:  Wilbur P Trey Williams; Dewey E McLin; Marlene A Dressman; David N Neubauer
Journal:  Pharmacotherapy       Date:  2016-09-01       Impact factor: 4.705

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.